Exocrine Pancreatic Insufficiency Pipeline Insights 2016 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/2q2c55/exocrine) has announced the addition of the "Exocrine Pancreatic Insufficiency-Pipeline Insights, 2016" report to their offering.

Exocrine Pancreatic Insufficiency-Pipeline Insights, 2016 provides in depth insight on the pipeline drugs and their development activities around the Exocrine Pancreatic Insufficiency.

The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

The Report covers the product clinical trials information and other development activities including technology, licensing, collaboration, acquisitions, funding, patent and USFDA & EMA designations details.

The Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Exocrine Pancreatic Insufficiency.

The report also assesses the Exocrine Pancreatic Insufficiency therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Key Topics Covered:

  1. Exocrine Pancreatic Insufficiency Overview
  2. Exocrine Pancreatic Insufficiency Pipeline Therapeutics
  3. Exocrine Pancreatic Insufficiency Therapeutics under Development by Companies
  4. Exocrine Pancreatic Insufficiency Filed and Phase III Products
  5. Comparative Analysis
  6. Exocrine Pancreatic Insufficiency Phase II Products
  7. Comparative Analysis
  8. Exocrine Pancreatic Insufficiency Phase I and IND Filed Products
  9. Comparative Analysis
  10. Exocrine Pancreatic Insufficiency Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Exocrine Pancreatic Insufficiency - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Exocrine Pancreatic Insufficiency - Discontinued Products
  19. Exocrine Pancreatic Insufficiency - Dormant Products
  20. Companies Involved in Therapeutics Development for Exocrine Pancreatic Insufficiency

For more information visit http://www.researchandmarkets.com/research/2q2c55/exocrine

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals